Cosmos Health Reports Record Revenue And Operating Metrics; Projects $12M Annualized U.S. NOOR Collagen Sales With 75% Gross Margins, Pursues U.S. Expansion And M&A Pipeline Including $11.5M Pharmacy Network Acquisition; Holds $18M In Non-Core Assets To Support Strategic Investments; Says Maintains Strong Growth Despite Geopolitical Turmoil; Plans To Issue Updated 2025 Operational, Strategic, And Financial Guidance Following Q4, FY25 Results - Cosmos Health (NASDAQ:COSM)
Published on March 19, 2026.
The company has reported a record-breaking year in sales and operating terms, with a $12M annualized revenue target for the coming year, and plans to issue an updated 2025 Operational, Strategic, and Financial Guidance. The company also plans to acquire $11.5M in non-core assets to support its expansion plans.
Read Original Article